Departure of Alexander Hardy & Appointment of Interim Chief Exec Officer at Genentech
Position
Chief Executive Officer
Company
Genentech
South San FranciscoManufacturingBiotechnologyHealth CareMedicalTherapeuticsresearchDescription
Alexander Hardy, Chief Executive Officer of Genentech, a member of the Roche Group, has decided to leave the company and will step down from his role on November 1st 2023. Hardy first joined Genentech in 2005 and held several senior management positions before assuming the role of CEO in March 2019. Ashley Magargee, Head of US Commercial Portfolio, who has been serving as ad interim CEO during Alexander’s recent sabbatical, will continue in this role until a successor is announced
Quick answer
Departure of Alexander Hardy & Appointment of Interim Chief Exec Officer at Genentech (November 7, 2023). Genentech is based in South San Francisco, California, United States.
- What did Genentech announce on November 7, 2023?
- Alexander Hardy, Chief Executive Officer of Genentech, a member of the Roche Group, has decided to leave the company and will step down from his role on November 1st 2023. Hardy first joined Genentech in 2005 and held several senior management positions before assuming the role of CEO in March 2019.
- What does Genentech do?
- Genentech is passionate about finding solutions for some of the world’s most difficult-to-treat conditions, using cutting-edge science to create and deliver innovative medicines worldwide.
- Where is Genentech based?
- Genentech is based in South San Francisco, California, United States.
- Which similar companies made leadership changes around the same time?
- Faeth Therapeutics (November 1, 2023), Rev.1 Engineering (November 6, 2023), OncoNano Medicine (November 6, 2023) and Century Therapeutics (November 9, 2023) also announced leadership changes within 45 days of Genentech.
Source: Fundz verified event record.
Other recent leadership changes in Medical and Therapeutics
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Sensei Biotherapeutics Appoints Stephanie Krebs, MS, MBA, as Chief Business Officer (November 1, 2023)
- Rev.1 Engineering Welcomes Scott Huter as New CEO (November 6, 2023)
- OncoNano Medicine Announces Promotion of Kartik Krishnan, MD, PhD, to President and Head of Research & Development (November 6, 2023)
- Century Therapeutics Appoints Brent Pfeiffenberger, Pharm.D., MBA, as Chief Executive Officer (November 9, 2023)
- Incendia Therapeutics Appoints Wendye Robbins, M.D., as Chief Executive Officer and Doses First Patient in Phase 1b Clinical Trial of PRTH-101, a Novel DDR1 Inhibitor (November 13, 2023)
- Aethlon Medical Announces Appointment of James B. Frakes, M.B.A. as Interim Chief Executive Officer and Guy Cipriani, M.B.A. as Chief Operating Officer (November 13, 2023)
Who to call at Genentech, and when
A new leader at Genentech brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Genentech raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Genentech, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Genentech. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Genentech changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Genentech changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.